The Roper St. Francis Neurosciences and Spine Program participates in FDA-approved clinical trials. Participation in clinical trials gives our patients access to the most up-to-date treatments for a specific disease, before they become broadly introduced.
July, 2007-completed study
NeuroThera Effectiveness and Safety Trial-2 (NEST-2)
A double blind, randomized, controlled, parallel group, multi-center, pivotal study to assess the safety and effectiveness of the treatment of acute ischemic stroke with the NeuroThera Laser System within 24 hours from stroke onset.
Search other clinical trials.